Skip to main content

Sands Capital Alternatives, LLC

13F filer · CIK 0001846444
Reported Aug 13, 2026
Net buyer this quarter
13F portfolio value$614MU.S. long equity reported on 13F
Positions243 new · 0 closed
Net flow last quarter+$161MBuys minus sells
Top 10 positions weight80.8%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 13, 202624 positions
ALMRAlamar Biosciences, Inc.$115M18.68%6.10%NewQ2 2026
NUNu Holdings Ltd.$94.8M15.45%Not reported+8.5%Q4 2021
KVYOKlaviyo, Inc.$59.3M9.67%Not reported+7.6%Q3 2023
BBNXBeta Bionics, Inc.$58.1M9.47%8.24%Not reportedQ1 2025
SGPSpyGlass Pharma, Inc.$55.7M9.07%7.47%Not reportedQ1 2026
IKTInhibikase Therapeutics, Inc.$26.4M4.31%9.86%Not reportedQ4 2024
DASHDoorDash, Inc.$23.5M3.84%Not reported+14.7%Q3 2021
CPNGCoupang, Inc.$23.1M3.76%Not reported+31.3%Q4 2022
DDOGDatadog, Inc.$21.1M3.43%0.10%-5.8%Q4 2022
BIOABioAge Labs, Inc.$19.3M3.14%1.72%Not reportedQ3 2024
TXG10x Genomics, Inc.$18.5M3.01%0.38%Not reportedQ2 2022
IOTSamsara Inc.$16.7M2.73%Not reported-8.0%Q4 2021
ODTXOdyssey Therapeutics, Inc.$16.4M2.67%1.83%NewQ2 2026
TOSTToast, Inc.$10.2M1.65%0.17%+21.0%Q4 2022
ABOSAcumen Pharmaceuticals, Inc.$9.93M1.62%5.14%Not reportedQ3 2021
TTANServiceTitan, Inc.$7.68M1.25%0.31%+20.8%Q4 2025
CBRSCerebras Systems Inc.$7.25M1.18%Not reportedNewQ2 2026
SNOWSnowflake Inc.$6.23M1.02%0.01%+21.0%Q3 2021
MNDYmonday.com Ltd.$5.93M0.97%0.16%+20.8%Q4 2024
TARSTarsus Pharmaceuticals, Inc.$5.35M0.87%0.20%Not reportedQ3 2021
TSHATaysha Gene Therapies, Inc.$4.94M0.80%0.22%Not reportedQ3 2021
CADLCandel Therapeutics, Inc.$4.18M0.68%0.53%Not reportedQ3 2021
ACRVAcrivon Therapeutics, Inc.$4.07M0.66%5.34%+7.9%Q4 2022
FIGFigma, Inc.$401K0.07%Not reported+21.2%Q3 2025
Q1 2026Reported May 8, 202621 positions
NUNu Holdings Ltd.$93.9M22.30%Not reported-4.7%Q4 2021
KVYOKlaviyo, Inc.$71M16.86%Not reportedNot reportedQ3 2023
SGPSpyGlass Pharma, Inc.$64.8M15.38%7.48%NewQ1 2026
BBNXBeta Bionics, Inc.$37.2M8.82%8.32%+3.9%Q1 2025
IKTInhibikase Therapeutics, Inc.$21.9M5.19%9.86%Not reportedQ4 2024
CPNGCoupang, Inc.$19.1M4.54%Not reported+16.3%Q4 2022
IOTSamsara Inc.$17.8M4.22%Not reported+20.2%Q4 2021
DASHDoorDash, Inc.$16.7M3.97%Not reported+16.3%Q3 2021
BIOABioAge Labs, Inc.$13.8M3.27%1.77%Not reportedQ3 2024
TXG10x Genomics, Inc.$10.2M2.43%0.38%Not reportedQ2 2022
DDOGDatadog, Inc.$10.1M2.40%0.11%Not reportedQ4 2022
ABOSAcumen Pharmaceuticals, Inc.$8.78M2.08%5.15%+8.9%Q3 2021
TOSTToast, Inc.$8M1.90%0.14%Not reportedQ4 2022
TARSTarsus Pharmaceuticals, Inc.$5.96M1.42%0.20%Not reportedQ3 2021
TTANServiceTitan, Inc.$5.7M1.35%0.25%Not reportedQ4 2025
MNDYmonday.com Ltd.$4.69M1.11%0.13%Not reportedQ4 2024
TSHATaysha Gene Therapies, Inc.$3.24M0.77%0.25%Not reportedQ3 2021
SNOWSnowflake Inc.$3.05M0.73%0.01%Not reportedQ3 2021
ACRVAcrivon Therapeutics, Inc.$2.95M0.70%5.48%Not reportedQ4 2022
CADLCandel Therapeutics, Inc.$1.99M0.47%0.55%Not reportedQ3 2021
FIGFigma, Inc.$387K0.09%Not reportedNot reportedQ3 2025
Q4 2025Reported Feb 13, 202620 positions
KVYOKlaviyo, Inc.$119M22.86%Not reported+3.8%Q3 2023
NUNu Holdings Ltd.$115M22.15%Not reported-4.4%Q4 2021
BBNXBeta Bionics, Inc.$109M20.98%8.05%Not reportedQ1 2025
IKTInhibikase Therapeutics, Inc.$26.7M5.15%9.89%+18.9%Q4 2024
DASHDoorDash, Inc.$21.7M4.18%Not reported+6.1%Q3 2021
CPNGCoupang, Inc.$20.5M3.96%Not reported+9.5%Q4 2022
IOTSamsara Inc.$16.5M3.19%Not reported-22.2%Q4 2021
DDOGDatadog, Inc.$11.7M2.25%0.11%-27.7%Q4 2022
TOSTToast, Inc.$10.7M2.07%0.14%+92.6%Q4 2022
BIOABioAge Labs, Inc.$10.4M2.01%2.10%Not reportedQ3 2024
MNDYmonday.com Ltd.$10M1.93%0.13%+16.3%Q4 2024
TTANServiceTitan, Inc.$9.57M1.85%0.25%NewQ4 2025
TXG10x Genomics, Inc.$7.86M1.52%0.38%Not reportedQ2 2022
ABOSAcumen Pharmaceuticals, Inc.$7.21M1.39%5.64%Not reportedQ3 2021
TARSTarsus Pharmaceuticals, Inc.$6.96M1.34%0.20%-50.0%Q3 2021
ACRVAcrivon Therapeutics, Inc.$5.12M0.99%6.71%Not reportedQ4 2022
SNOWSnowflake Inc.$4.44M0.86%0.01%-25.0%Q3 2021
TSHATaysha Gene Therapies, Inc.$3.99M0.77%0.25%Not reportedQ3 2021
CADLCandel Therapeutics, Inc.$2.29M0.44%0.74%Not reportedQ3 2021
FIGFigma, Inc.$683K0.13%Not reportedNot reportedQ3 2025
Q3 2025Reported Nov 13, 202520 positions
NUNu Holdings Ltd.$115M25.17%Not reportedNot reportedQ4 2021
KVYOKlaviyo, Inc.$97.3M21.33%Not reportedNot reportedQ3 2023
BBNXBeta Bionics, Inc.$70.9M15.54%8.12%Not reportedQ1 2025
CPNGCoupang, Inc.$25.6M5.61%Not reportedNot reportedQ4 2022
DASHDoorDash, Inc.$24.5M5.37%Not reportedNot reportedQ3 2021
IOTSamsara Inc.$22.3M4.89%Not reportedNot reportedQ4 2021
IKTInhibikase Therapeutics, Inc.$17.7M3.89%14.64%Not reportedQ4 2024
DDOGDatadog, Inc.$16.9M3.70%0.15%Not reportedQ4 2022
MNDYmonday.com Ltd.$11.3M2.48%0.11%Not reportedQ4 2024
TARSTarsus Pharmaceuticals, Inc.$10.1M2.21%0.40%Not reportedQ3 2021
CRWDCrowdStrike Holdings, Inc.$7.66M1.68%0.01%Not reportedQ4 2022
SNOWSnowflake Inc.$6.09M1.33%0.01%Not reportedQ3 2021
ABOSAcumen Pharmaceuticals, Inc.$5.84M1.28%5.64%Not reportedQ3 2021
TOSTToast, Inc.$5.72M1.25%0.07%Not reportedQ4 2022
TXG10x Genomics, Inc.$5.63M1.23%0.39%Not reportedQ2 2022
BIOABioAge Labs, Inc.$4.62M1.01%2.19%Not reportedQ3 2024
ACRVAcrivon Therapeutics, Inc.$3.84M0.84%6.73%Not reportedQ4 2022
TSHATaysha Gene Therapies, Inc.$2.37M0.52%0.26%Not reportedQ3 2021
CADLCandel Therapeutics, Inc.$2.07M0.45%0.74%Not reportedQ3 2021
FIGFigma, Inc.$948K0.21%Not reportedNewQ3 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.